Keyphrases
Ovarian Cancer
100%
UNC-45
83%
Microtubules
66%
Tumor
62%
ARID1A
55%
Paclitaxel
43%
Ovarian Clear Cell Carcinoma
39%
High-grade Serous Ovarian Cancer (HGSOC)
35%
Microtubule Lattice
33%
Microtubule-severing Proteins
31%
Divergence
31%
Taxol
30%
Ovarian Cancer Cells
30%
Paclitaxel-resistant
30%
Mesenchymal Stem Cells
27%
Seurat
27%
Epithelial Cells
27%
Nanoparticles
27%
Protective Factors
27%
Targeted Drug Delivery
27%
Guidepost
27%
Microbiome
27%
Endometrial Cancer Cells
27%
Parameter Setting
27%
Cancer Treatment
27%
Neoadjuvant Chemotherapy
27%
Biologists
27%
Clear Cell Carcinoma of the Ovary
27%
Paclitaxel Sensitivity
27%
Multi-omics Analysis
27%
Colorectal Cancer
27%
Non-muscle Myosin II
27%
Fecal Microbiota
27%
Carboplatin
27%
Molecular Targets
27%
Mitochondrial Metabolism
27%
Endometrial Cancer
27%
Microtubule-associated Protein
27%
Inflammation
27%
Chemotherapy Resistance
27%
Biological Insight
27%
Glutaminase 1 (GLS1)
27%
Single-cell RNA Sequencing Data
27%
Cluster Solutions
27%
RNA Sequencing (RNA-seq)
27%
Nervous System
27%
Proliferating Cells
27%
Kirsten Rat Sarcoma Virus
27%
Genital Tract
27%
Intercellular Transfer
27%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
92%
Myosin ATPase
83%
ARID1A
55%
RNA Sequence
55%
Adenosine Triphosphate
50%
Mitosis Spindle
46%
Muscle Contractility
41%
Tumor Gene
41%
Gene Expression
36%
Fluorescence Microscopy
36%
Myosin
36%
Carcinogenesis
36%
Genomics
32%
Microtubule-Associated Protein
27%
Solution and Solubility
27%
Cell Proliferation
27%
Kirsten Murine Sarcoma Virus
27%
Mitochondrial Respiration
27%
Interphase
27%
Drug Resistance
27%
Glutaminase
27%
Colon
27%
Chlordiazepoxide
27%
RNA Sequencing
27%
Proteogenomics
27%
Proteome
27%
Transcriptome
27%
Escherichia coli
27%
Cell Cycle
13%
Differential Gene Expression
13%
RNA Extraction
13%
Drug Transport
13%
Peroxisome
13%
Gene Signature
13%
Mass Spectrometry
13%
Proteomics
13%
Genome-Wide Analysis of Gene Expression
13%
Recombinant
13%
Katanin
13%
Overall Survival
13%
Dynamics
9%
Tubulin
9%
Aneuploidy
9%
Small Molecule
9%
Cell Motility
9%
ADAMTS5
9%
Bulk RNA Sequencing
9%
Ploidy
9%
Stromal Cell
9%
Pharmacogenomics
9%
Medicine and Dentistry
Neoplasm
46%
Ovarian Cancer
43%
Paclitaxel
33%
Cancer Cell
30%
Carboplatin
27%
Glutaminase
27%
Prostate Specific Membrane Antigen
27%
Prostate Cancer
27%
Natural Killer Cell
27%
Nervous System
27%
Proteogenomics
27%
Protective Factor
27%
RNA Sequence
27%
Cancer Therapy
27%
Uterine Cancer
27%
Microtubule
27%
Xenograft
27%
Cell Proliferation
27%
Cytotoxicity
27%
Clear Cell Carcinoma
27%
Myosin Adenosine Triphosphatase
11%
Castration Resistant Prostate Cancer
10%
Recurrent Disease
9%
Proteome
9%
Drug Resistance
9%
Cancer
8%
Neurodegeneration
5%
Female Reproductive Tract
5%
Muscle Contractility
5%
Ciliated Epithelium
5%
Pathophysiology
5%
Central Nervous System
5%
Tumor Microenvironment
5%
